Immuron Ltd. Files October 2024 6-K Report

TL;DR

Immuron Ltd. filed its October 6-K, confirming foreign private issuer status and 20-F filing for annual reports.

AI Summary

On October 16, 2024, Immuron Ltd. filed a Form 6-K, reporting information for the month of October 2024. The filing indicates that Immuron Limited is a foreign private issuer and will file annual reports under Form 20-F. The company's principal executive office is located in Carlton South, Victoria, Australia.

Why It Matters

This filing provides an update on Immuron Ltd.'s regulatory reporting status and confirms its classification as a foreign private issuer, which impacts its SEC filing requirements.

Risk Assessment

Risk Level: low — This filing is primarily administrative and procedural, confirming the company's reporting status without disclosing significant financial or operational changes.

Key Players & Entities

• Immuron Ltd. (company) — Registrant
• October 2024 (date) — Reporting period
• Form 6-K (document) — Filing type
• Form 20-F (document) — Annual report form
• Carlton South, Victoria, Australia (location) — Principal executive office address

FAQ

Filing Documents

• ea0217757-6k_immuron.htm (6-K) — 13KB
• ea021775701ex99-1_immuron.htm (EX-99.1) — 43KB
• ex99-1_001.jpg (GRAPHIC) — 19KB
• ex99-1_002.jpg (GRAPHIC) — 6KB
• ex99-1_003.jpg (GRAPHIC) — 3KB
• ex99-1_004.jpg (GRAPHIC) — 754KB
• ex99-1_005.jpg (GRAPHIC) — 819KB
• ex99-1_006.jpg (GRAPHIC) — 890KB
• ex99-1_007.jpg (GRAPHIC) — 590KB
• ex99-1_008.jpg (GRAPHIC) — 670KB
• ex99-1_009.jpg (GRAPHIC) — 1035KB
• ex99-1_010.jpg (GRAPHIC) — 751KB
• ex99-1_011.jpg (GRAPHIC) — 918KB
• ex99-1_012.jpg (GRAPHIC) — 597KB
• ex99-1_013.jpg (GRAPHIC) — 963KB
• ex99-1_014.jpg (GRAPHIC) — 409KB
• 0001213900-24-087977.txt ( ) — 11660KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 16, 2024 titled: - “IMC CEO to participate in Maxim Healthcare Conference - addendum” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 IMC CEO to participate in Maxim Healthcare Conference - addendum 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 16, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR